Literature DB >> 6161374

Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein.

N Eriksen, E P Benditt.   

Abstract

Two apoproteins immunologically related to the 9000-dalton abnormal tissue constituent known as amyloid protein AA were isolated from the lipoprotein density interval 1.125-1.21 g/cm3 (HDL3) of a pool of human serums by delipidation, gel filtration, and ion-exchange chromatography. Lesser amounts of the same apoproteins were isolated from the density interval 1.063-1.125 g/cm3 (HDL2). These apoproteins, designated apoSAA1 and apoSAA2, have molecular weights near 11,500, almost identical amino acid compositions, and slightly different isoelectric points. Their amino acid sequences are identical as far as determined (30 residues), except that apoSAA2 lacks the NH2-terminal arginine found in apoSAA1. The sequence is homologous with that of amyloid protein AA, which thus has residing in the plasma high density lipoproteins a potential precursor whose biological significance and function remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161374      PMCID: PMC350390          DOI: 10.1073/pnas.77.11.6860

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Isolation and characterization of two threonine-poor apolipoproteins of human plasma high density lipoproteins.

Authors:  V G Shore; B Shore; S B Lewis
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

2.  Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery.

Authors:  P D Gorevic; C J Rosenthal; E C Franklin
Journal:  Clin Immunol Immunopathol       Date:  1976-07

3.  Amino acid sequence of an amyloid fibril protein of unknown origin.

Authors:  D Ein; S Kimura; W D Terry; J Magnotta; G G Glenner
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

4.  Chemical similarity among amyloid substances associated with long standing inflammation.

Authors:  E P Benditt; N Eriksen
Journal:  Lab Invest       Date:  1972-06       Impact factor: 5.662

Review 5.  Classification of amyloid: 1979--1980.

Authors:  A S Cohen; O Wegelius
Journal:  Arthritis Rheum       Date:  1980-06

6.  Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

Authors:  R P Linke; J D Sipe; P S Pollock; T F Ignaczak; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

8.  Isolation and partial characterization of SAA-an amyloid-related protein from human serum.

Authors:  C J Rosenthal; E C Franklin; B Frangione; J Greenspan
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

9.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

10.  Amyloid-related serum protein SAA from three animal species: comparison with human SAA.

Authors:  R F Anders; J B Natvig; K Sletten; G Husby; K Nordstoga
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

View more
  23 in total

1.  Heterogeneity of serum amyloid A with respect to molecular mass.

Authors:  F Ogata
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

2.  Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells.

Authors:  J H Huang; H Y Rienhoff; W S Liao
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins.

Authors:  C A van de Kaa; P R Hol; J Huber; R P Linke; C J Kooiker; E Gruys
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Serum amyloid A in the mouse. Sites of uptake and mRNA expression.

Authors:  R L Meek; N Eriksen; E P Benditt
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

5.  Metabolism of the serum amyloid A proteins (SSA) in high-density lipoproteins and chylomicrons of nonhuman primates (vervet monkey).

Authors:  J S Parks; L L Rudel
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

6.  Identification of three isoform patterns of human serum amyloid A protein.

Authors:  A F Strachan; F C de Beer; D R van der Westhuyzen; G A Coetzee
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

7.  Immunization with pneumococcal polysaccharide serotype 3 and lipopolysaccharide modulates lung and liver inflammation during a virulent Streptococcus pneumoniae infection in mice.

Authors:  Katherine H Restori; Mary J Kennett; A Catharine Ross
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

8.  Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis.

Authors:  Erik R M Eckhardt; Jassir Witta; Jian Zhong; Razvan Arsenescu; Violeta Arsenescu; Yu Wang; Sarbani Ghoshal; Marcielle C de Beer; Frederick C de Beer; Willem J S de Villiers
Journal:  BMC Gastroenterol       Date:  2010-11-10       Impact factor: 3.067

9.  Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).

Authors:  G Marhaug; K Sletten; G Husby
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

10.  Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences.

Authors:  K Yamamoto; S Migita
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.